Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by E Londin
GPRC5A Is a Potential Oncogene in Pancreatic Ductal Adenocarcinoma Cells That Is Upregulated by Gemcitabine With Help From HuR
Cell Death and Disease
Molecular Neuroscience
Immunology
Cell Biology
Cancer Research
Cellular
Medicine
Related publications
Interstitial Pressure in Pancreatic Ductal Adenocarcinoma Is Dominated by a Gel-Fluid Phase
Biophysical Journal
Biophysics
Increased Expression of Plakoglobin Is Associated With Upregulated MAPK and PI3K/AKT Signalling Pathways in Early Resectable Pancreatic Ductal Adenocarcinoma
Oncology Letters
Cancer Research
Oncology
HMGA1 Is a Molecular Determinant of Chemoresistance to Gemcitabine in Pancreatic Adenocarcinoma
Clinical Cancer Research
Cancer Research
Oncology
GPRC5A: A Potential Tumor Suppressor and Oncogene
Cancer Biology and Therapy
Cancer Research
Oncology
Molecular Medicine
Pharmacology
Increased CDC20 Expression Is Associated With Pancreatic Ductal Adenocarcinoma Differentiation and Progression
Journal of Hematology and Oncology
Cancer Research
Oncology
Hematology
Molecular Biology
Elevated McP-1 Is Associated With Cancer Cachexia in Patients With Pancreatic Ductal Adenocarcinoma
HPB
Hepatology
Gastroenterology
ST6Gal-I Sialyltransferase Promotes Chemoresistance in Pancreatic Ductal Adenocarcinoma by Abrogating Gemcitabine-Mediated DNA Damage
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
P8 Is a New Target of Gemcitabine in Pancreatic Cancer Cells
Clinical Cancer Research
Cancer Research
Oncology
CCAT2 Is an Oncogenic Long Non-Coding RNA in Pancreatic Ductal Adenocarcinoma
Biological Research
Genetics
Molecular Biology
Biochemistry
Biological Sciences
Medicine
Agricultural
